Headache / Migraine News From Medical News Today
Thu, 02 Sep 2010 18:53:59 +0200
Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor
Allergan Inc., the makers of BOTOX (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company's past sales and marketing practices related to specific therapeutic uses of BOTOX...
Wed, 01 Sep 2010 11:00:00 PDT
Genetic Link To Migraine Found, In DNA Variant On Chromosome 8
Scientists have identified the first genetic risk factor linked to a common type of migraine after examining the genetic data of over 50,000 individuals. The investigators say that this breakthrough gives them new insights into migraine triggers, which will hopefully lead to novel therapies to prevent episodes of migraine...
Mon, 30 Aug 2010 10:00:00 PDT
Recurrent Teen Headaches Linked To Smoking, Overweight And Physical Inactivity
Teenagers who regularly have headaches may find that their problem is linked to overweight, smoking and/or lack of physical exercise, according to an article published in the medical journal Neurology. The authors found that teenagers with all three factors - those who were overweight, smoked and did very little exercise - were 3...
Thu, 19 Aug 2010 08:00:00 PDT
Headaches In Teens Tied To Overweight, Smoking And Lack Of Exercise
Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. Teens with all three of the negative lifestyle factors were 3...
Thu, 19 Aug 2010 04:00:00 PDT
Nautilus Neurosciences Announces U.S. Launch Of CAMBIA(TM) (Diclofenac Potassium For Oral Solution) For The Treatment Of Migraine
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009...
Sat, 07 Aug 2010 02:00:00 PDT
BOTOX(R) Receives First Authorisation In UK As Preventative Treatment In Chronic Migraine
Allergan has today announced that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1...
Mon, 12 Jul 2010 04:00:00 PDT
HeadCoolieTM Adjustable, Reusable Head Wrap Provides Non-Chemical, Non-Prescription Therapeutic Relief For Fever Symptoms And Headaches
American Diversified Medical Corporation, a majority owned subsidiary of ThermaFreeze Products Corporation (PINKSHEETS: TZPC), unveiled its newest product line, the HeadCoolie™...
Fri, 09 Jul 2010 02:00:00 PDT
A Simple Massage Is Proven To Relieve Psychological And Physiological State Of Patients With Chronic Tension Headache
Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage. As researchers explained, tension headaches have an increasing incidence in the population...
Fri, 09 Jul 2010 02:00:00 PDT
GlaxoSmithKline And XenoPort Report Top-Line Phase 2b Results For GSK1838262/XP13512 As A Prophylactic Treatment For Migraine Headache
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches...
Fri, 09 Jul 2010 01:00:00 PDT
REM Sleep Deprivation Plays A Role In Chronic Migraine
Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine. Paul L. Dunham, Ph.D...
Thu, 24 Jun 2010 00:00:00 PDT
|